Advertisement
Screener

Gene Biotherapeutics, Inc. Total Assets

Gene Biotherapeutics, Inc. Total Assets

Gene Biotherapeutics, Inc. had Total Assets of $566.98 thousand as of 2020-12-31, per its 10-K/A filed 2022-04-14.

Discontinued › Balance Sheet › Assets

us-gaap:Assets · last filed 2022-04-14

  • 2020-12-31: Assets $566.98K.
  • 2020-09-30: Assets $974.82K.
  • 2020-06-30: Assets $1.34M.
  • 2020-03-31: Assets $129.67K.
Period endAssets
2020-12-31$566.98K
10-K/A · filed 2022-04-14
2020-09-30$974.82K
10-Q · filed 2021-10-27
2020-06-30$1.34M
10-Q · filed 2021-09-17
2020-03-31$129.67K
10-Q · filed 2021-09-03
2019-12-31$35.44K
10-K/A · filed 2022-04-14
2019-09-30$67.01K
10-K · filed 2021-04-23
2019-06-30$41.79K
10-K · filed 2021-04-23
2019-03-31$62.94K
10-K · filed 2021-04-23
2018-12-31$161.90K
10-K · filed 2021-04-23
2018-09-30$276.48K
10-K · filed 2021-04-23
2018-06-30$140.48K
10-K · filed 2021-04-23
2018-03-31$120.78K
10-K · filed 2021-04-23
2017-12-31$209.77K
10-K · filed 2021-04-23
2017-09-30$170.39K
10-K · filed 2021-04-23
2017-06-30$220.36K
10-K · filed 2021-04-23
2017-03-31$373.93K
10-K · filed 2021-04-23
2016-12-31$1.11M
10-K · filed 2017-07-28
2016-09-30$1.95M
10-Q · filed 2017-03-21
2016-06-30$24.61K
10-Q · filed 2017-03-06
2016-03-31$131.77K
10-Q · filed 2017-03-01
2015-12-31$37.30K
10-K · filed 2017-07-28
2015-09-30$46.78K
10-Q · filed 2016-10-27
2015-06-30$169.98K
10-Q · filed 2016-08-29
2015-03-31$550.47K
10-Q · filed 2015-06-18
2014-12-31$746.09K
10-K · filed 2016-12-29
2014-09-30$1.98M
10-Q · filed 2014-11-19
2014-06-30$3.41M
10-Q · filed 2014-08-12
2014-03-31$2.97M
10-Q · filed 2014-05-15
2013-12-31$2.79M
10-K · filed 2015-05-22
2013-09-30$5.13M
10-Q · filed 2013-11-19
2013-06-30$5.48M
10-Q · filed 2013-08-14
2013-03-31$5.46M
10-Q · filed 2013-05-15
2012-12-31$7.81M
10-K · filed 2014-04-15
2012-09-30$9.58M
10-Q · filed 2012-11-14
2012-06-30$9.26M
10-Q · filed 2012-08-14
2012-03-31$11.79M
10-Q · filed 2012-05-15
2011-12-31$7.50M
10-K · filed 2013-04-05
2011-09-30$3.95M
10-Q · filed 2011-11-14
2011-06-30$5.87M
10-Q · filed 2011-08-15
2010-12-31$9.51M
10-K · filed 2012-03-30